group A bimatoprost 0.03% eye drops once daily for a period of 4 weeks	group B brimonidine 0.2% eye drops twice daily for a period of 4 weeks	IOP (intraocular pressure)	13108	13332	As shown in Table 2, absolute fall in IOP with bimatoprost was by 8.9 ± 1.598 mm Hg by the final visit. This was significantly (P < 0.0001) higher than the reduction of 6.55 ± 1.26 mm Hg seen in brimonidine-treated patients.
group A bimatoprost 0.03% eye drops once daily for a period of 4 weeks	group B brimonidine 0.2% eye drops twice daily for a period of 4 weeks	IOP (intraocular pressure)	1373	1498	IOP lowering with bimatoprost (8.9 ± 1.598 mm Hg) was significantly (P < 0.0001) higher than brimonidine (6.55 ± 1.26 mm Hg).
